Annual Results Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 12.26% vs 13.50% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is 109.03% vs 29.60% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 24.58% vs 24.79% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 37.78% vs 45.16% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of RPG LifeScience. With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
653.43
399.84
253.59
63.42%
Other Operating Income
0.00
0.00
0.00
Total Operating income
653.43
399.84
253.59
63.42%
Raw Material Cost
110.26
117.01
-6.75
-5.77%
Purchase of Finished goods
95.14
0.00
95.14
(Increase) / Decrease In Stocks
8.61
14.00
-5.39
-38.50%
Employee Cost
126.14
90.15
35.99
39.92%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
153.63
106.89
46.74
43.73%
Total Expenditure (Excl Depreciation)
493.78
328.05
165.73
50.52%
Operating Profit (PBDIT) excl Other Income
159.65
71.79
87.86
122.38%
Other Income
12.68
32.98
-20.30
-61.55%
Operating Profit (PBDIT)
172.33
104.77
67.56
64.48%
Interest
0.62
70.40
-69.78
-99.12%
Exceptional Items
82.60
0.00
82.60
Gross Profit (PBDT)
254.31
34.37
219.94
639.92%
Depreciation
21.43
65.20
-43.77
-67.13%
Profit Before Tax
232.88
-30.83
263.71
855.37%
Tax
49.64
-20.96
70.60
336.83%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
183.24
-9.87
193.11
1,956.53%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
183.24
-9.87
193.11
1,956.53%
Equity Capital
13.23
31.36
-18.13
-57.81%
Face Value
8.00
2.00
0.00
Reserves
517.30
3,999.12
-3,481.82
-87.06%
Earnings per share (EPS)
110.80
-0.63
111.43
17,687.30%
Diluted Earnings per share
110.80
-0.63
111.43
17,687.30%
Operating Profit Margin (Excl OI)
24.43%
17.95%
0.00
6.48%
Gross Profit Margin
38.92%
8.60%
0.00
30.32%
PAT Margin
28.04%
-2.47%
0.00
30.51%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 653.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 12.26% vs 13.50% in Mar 2024
Annual - Standalone Net Profit
Standalone Net Profit 183.24 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 109.03% vs 29.60% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 159.65 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 24.58% vs 24.79% in Mar 2024
Annual - Interest
Interest 0.62 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 37.78% vs 45.16% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.43%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
